FDA approves new treatment for cystic fibrosis

The U.S. Food and Drug Administration today approved the first drug for cystic fibrosis directed at treating the cause of the disease in people who have two copies of a specific mutation.

Source: Food and Drug Administration - July 2, 2015 Category: American Health Source Type: news